BamSEC and AlphaSense Join Forces
Learn More

Intercept Pharmaceuticals, Inc. – Indentures

Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 6 pages Second Supplemental Indenture
12/34/56
EX-4.1
from 8-K 5 pages Third Supplemental Indenture
12/34/56
EX-4.3
from S-3ASR 43 pages Intercept Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 40 pages Intercept Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.9
from 10-K 3 pages Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 ​ Description of the Registrant's Common Stock ​
12/34/56
EX-4.11
from 10-K 3 pages Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 ​ Description of the Registrant's Common Stock ​
12/34/56
EX-4.2
from 8-K 136 pages Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee and Collateral Agent First Supplemental Indenture Dated as of August 17, 2021 to Indenture for Senior Debt Securities Dated as of August 17, 2021 3.50% Convertible Senior Secured Notes Due 2026
12/34/56
EX-4.1
from 8-K 51 pages Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of August 17, 2021 Senior Debt Securities
12/34/56
EX-4.11
from 10-K 3 pages Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 ​ Description of the Registrant's Common Stock ​
12/34/56
EX-4.11
from 10-K 3 pages Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of the Registrant's Common Stock
12/34/56
EX-4.2
from 8-K 92 pages Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee Second Supplemental Indenture Dated as of May 14, 2019 to Indenture for Senior Debt Securities Dated as of July 6, 2016 2.00% Convertible Senior Notes Due 2026
12/34/56
EX-4.4
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 60 pages Intercept Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 55 pages Intercept Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.2
from 8-K 90 pages Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee First Supplemental Indenture Dated as of July 6, 2016 to Indenture for Senior Debt Securities Dated as of July 6, 2016 3.25% Convertible Senior Notes Due 2023
12/34/56
EX-4.1
from 8-K 56 pages Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of July 6, 2016 Senior Debt Securities
12/34/56
EX-4.4
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 60 pages Intercept Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56